Crossref
Design And Characterization of Bilastine Nanoparticles to Treat Allergic Rhinitis and Chronic Urticaria
International Journal of Drug Delivery Technology · 12.08.2026 · 16 (74s)
DOI: 10.25258/ijddt.16.74s.85 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, erschienen am 12.08.2026. Verfasst von Naveen Jamjala und 2 weiteren Autor:innen.
Abstract (Originalsprache)
.
Zitieren
APA
Jamjala, N., MadhuvarshiniK, M., & Podichety, N. (2026). Design And Characterization of Bilastine Nanoparticles to Treat Allergic Rhinitis and Chronic Urticaria. International Journal of Drug Delivery Technology, 16(74s). https://doi.org/10.25258/ijddt.16.74s.85
Vancouver
Jamjala N, MadhuvarshiniK M, Podichety N. Design And Characterization of Bilastine Nanoparticles to Treat Allergic Rhinitis and Chronic Urticaria. International Journal of Drug Delivery Technology. 2026;16(74s). doi:10.25258/ijddt.16.74s.85
BibTeX
@article{Jamjala2026,
author = {Jamjala, Naveen and MadhuvarshiniK, MadhuvarshiniK and Podichety, Neeraja},
title = {Design And Characterization of Bilastine Nanoparticles to Treat Allergic Rhinitis and Chronic Urticaria},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {74s},
doi = {10.25258/ijddt.16.74s.85}
}
EUVIMED